APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
APPENDICES - NIHR Health Technology Assessment Programme
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
154<br />
Appendix 7<br />
in oesophageal pre-neoplastic and malignant<br />
neoplastic lesions of the oesophagus: a review study.<br />
Photodynamic Therapy and Photodiagnosis in<br />
Clinical Practice, Brixen/Bressanone. 7–11 October<br />
2008. Session 6 – invited lecture.<br />
59. Ohana M, Mino-Kenudson M, Ban S, Puricelli<br />
W, Nishioka N. Frequent persistence of dysplasia<br />
by systematic pathological evaluation after<br />
photodynamic therapy for Barrett’s esophagus with<br />
high-grade dysplasia or early adenocarcinoma.<br />
Gastroenterology 2005;129:1109.<br />
60. Ohana M, Mino-Kenudson M, Ban S, Puricelli<br />
W, Nishoka N. Frequent persistence of dysplasia<br />
by systematic pathological evaluation after<br />
photodynamic therapy for Barrett’s Esophagus<br />
with high-grade dysplasia or early adenocarcinoma.<br />
Gastrointest Endosc 2005;61:A94.<br />
61. Ohana M, Mino-Kenudson M, Ban SC, Puricelli<br />
W, Nishioka N, Lauwers G. Frequent persistence<br />
of dysplasia by systematic pathological evaluation<br />
after photodynamic therapy for Barrett’s Esophagus<br />
with high-grade dysplasia or early adenocarcinoma.<br />
Gastroenterology 2005;128:A72.<br />
62. Ortner MA, Zumbusch K, Liebetruth J, Ebert<br />
B, Fleige B, Dietel M, et al. Is topical deltaaminolevulinic<br />
acid adequate for photodynamic<br />
therapy in Barrett’s esophagus? A pilot study.<br />
Endoscopy 2002;34:611–16.<br />
63. Overholt B, Panjehpour M, Tefftellar E, Rose<br />
M. Photodynamic therapy for treatment of early<br />
adenocarcinoma in Barrett’s esophagus. Gastrointest<br />
Endosc 1993;39:73–6.<br />
64. Overholt BF, Panjehpour M. Photodynamic therapy<br />
in Barrett’s esophagus: reduction of specialized<br />
mucosa, ablation of dysplasia, and treatment of<br />
superficial esophageal cancer. Semin Surg Oncol<br />
1995;11:372–6.<br />
65. Overholt BF, Panjehpour M. Barrett’s esophagus:<br />
photodynamic therapy for ablation of dysplasia,<br />
reduction of specialized mucosa, and treatment of<br />
superficial esophageal cancer. Gastrointest Endosc<br />
1995;42:64–70.<br />
66. Overholt BF, Panjehpour M. Barretts esophagus<br />
– photodynamic therapy for ablation of dysplasia,<br />
reduction of specialized mucosa and treatment of<br />
superficial esophageal cancer. SPIE Proceedings Series<br />
1995;2371:375–84.<br />
67. Overholt BF, Panjehpour M. Photodynamic therapy<br />
in Barrett’s esophagus. J Clin Laser Med Surg<br />
1996;14:245–9.<br />
68. Overholt BF, Panjehpour M. Photodynamic therapy<br />
for Barrett’s esophagus: clinical update. Am J<br />
Gastroenterol 1996;91:1719–23.<br />
69. Overholt BF, Panjehpour M. Photodynamic therapy<br />
for Barrett’s esophagus. Gastrointest Endosc Clin N<br />
Am 1997;7:207–20.<br />
70. Overholt BF, Panjehpour M, Ayres M.<br />
Photodynamic therapy for Barrett’s esophagus:<br />
cardiac effects. Lasers Surg Med 1997;21:317–20.<br />
71. Overholt BF, Panjehpour M, Halberg DL.<br />
Photodynamic therapy for Barrett’s esophagus with<br />
dysplasia and/or early stage carcinoma: long-term<br />
results. Gastrointest Endosc 2003;58:183–8.<br />
72. Overholt BF, Panjehpour M, Halberg DL.<br />
Photodynamic therapy for Barrett’s esophagus with<br />
dysplasia and/or early stage carcinoma: long-term<br />
results. Gastrointest Endosc 2003;58:183–8.<br />
73. Overholt BF, Panjehpour M, Haydek JM.<br />
Photodynamic therapy for Barrett’s esophagus:<br />
follow-up in 100 patients. Gastrointest Endosc<br />
1999;49:1–7.<br />
74. Pacifico RJ, Wang KK, Wongkeesong L-M,<br />
Buttar NS, Lutzke LS. Combined endoscopic<br />
mucosal resection and photodynamic therapy<br />
versus esophagectomy for management of early<br />
adenocarcinoma in Barrett’s esophagus. Clin<br />
Gastroenterol Hepatol 2003;1:252–7.<br />
75. Panjehpour M, Overholt BF, Dougherty TJ.<br />
Photodynamic therapy in Barrett’s esophagus:<br />
review of current results. SPIE Proceedings Series<br />
1996;2675:20–8.<br />
76. Panjehpour M, Overholt BF, Dougherty TJ.<br />
Photodynamic therapy of dysplasia in Barrett’s<br />
esophagus: an update. SPIE Proceedings Series<br />
1997;2972:27–36.<br />
77. Panjehpour M, Overholt BF, Haydek JM, Dougherty<br />
TJ. Photodynamic therapy with photofrin followed<br />
by thermal ablation for elimination of dysplasia and<br />
early cancer in Barrett’s esophagus: follow-up in 100<br />
patients. SPIE Proceedings Series 1998;3247:14–24.<br />
78. Panjehpour M, Overholt BF, Phan MN, Haydek JM,<br />
Robinson AF. Photodynamic therapy for Barrett’s<br />
esophagus using a 20-mm diameter light-delivery<br />
balloon (invited paper). SPIE Proceedings Series<br />
2002;4612:13–20.<br />
79. Panjehpour M, Phan MN, Overholt BF. Relationship<br />
between acute mucosal injury, treatment efficacy<br />
and esophageal stricture following photodynamic<br />
therapy of Barrett’s esophagus. Gastrointest Endosc<br />
2004;59:A251.